INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 18, 2008 |
Director
Trans History: 742
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 1,822 |
Dec 18, 2008 |
Director
Trans History: 742
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 114,309 |
Dec 18, 2008 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Other acquisition or disposition | -- | -- | 4,330 |
Dec 17, 2008 |
SVP F&A, CFO, Treas, & Ast Sec
Trans History: 645
|
SVP F&A, CFO, Treas, & Ast Sec | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,952 | -- | 5,952 |
Dec 17, 2008 |
SVP F&A, CFO, Treas, & Ast Sec
Trans History: 645
|
SVP F&A, CFO, Treas, & Ast Sec | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 31,548 | -- | 31,548 |
Dec 17, 2008 |
SVP, Gen Counsel & Secretary
Trans History: 117
|
SVP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,952 | -- | 5,952 |
Dec 17, 2008 |
SVP, Gen Counsel & Secretary
Trans History: 117
|
SVP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,048 | -- | 19,048 |
Dec 17, 2008 |
VP, Controller and Asst. Treas
Trans History: 372
|
VP, Controller and Asst. Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- | 5,000 |
Dec 17, 2008 |
VP, Controller and Asst. Treas
Trans History: 372
|
VP, Controller and Asst. Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Dec 17, 2008 |
SVP, Clinical Development
Trans History: 208
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- | 5,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.